News
26 October, 2022 - 19:00 (CEST)
Announcement
M
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
The following APIs were added:
- APIs for products used in the treatment of hepatitis B and C
- Glecaprevir
- Pibrentasvir
The following APIs were deleted:
- APIs for products used in the treatment of hepatitis B and C
- Dasabuvir
- Ombitasvir
- Paritaprevir
- Ritonavir